Angiotensin II produces nociceptive behavior through spinal AT1 receptor-mediated p38 mitogen-activated protein kinase activation in mice

Molecular Pain

Volumn 9, Issue 1, 2013, Pages

  Nemoto, Wataru ^a   Nakagawasai, Osamu ^a   Yaoita, Fukie ^a   Kanno, Syu Ichi ^a   Yomogida, Shin ^a   Ishikawa, Masaaki ^a   Tadano, Takeshi ^b   Tan No, Koichi ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MORPHINE; STRESS ACTIVATED PROTEIN KINASE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANGIOTENSIN 1 RECEPTOR; IMIDAZOLE DERIVATIVE; PYRIDINE DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BITE; LICKING; MALE; MOUSE; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SCRATCHING; SPINAL CORD DORSAL HORN; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; METABOLISM; SIGNAL TRANSDUCTION; SPINAL CORD;

ANGIOTENSIN II; ANIMALS; IMIDAZOLES; LOSARTAN; MALE; MAP KINASE SIGNALING SYSTEM; MICE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; RECEPTOR, ANGIOTENSIN, TYPE 1; SPINAL CORD;

EID: 84880903419     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-9-38     Document Type: Article

References (53)

1. Paul M, Poyan Mehr A, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev 2006, 86:747. 10.1152/physrev.00036.2005, 16816138.
2. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000, 52:415-472.
3. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smith RD. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993, 45:205-251.
4. Bader M. Tissue renin-angiotensin-aldosterone systems: Targets for pharmacological therapy. Annu Rev Pharmacol Toxicol 2010, 50:439-465. 10.1146/annurev.pharmtox.010909.105610, 20055710.
5. Villarreal FJ, Kim NN, Ungab GD, Printz MP, Dillmann WH. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation 1993, 88:2849-2861. 10.1161/01.CIR.88.6.2849, 8252698.
6. Nguyen Dinh Cat A, Touyz RM. A new look at the renin-angiotensin system--focusing on the vascular system. Peptides 2011, 32:2141-2150. 10.1016/j.peptides.2011.09.010, 21945916.
7. Zhuo JL, Li XC. New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II. Peptides 2011, 32:1551-1565. 10.1016/j.peptides.2011.05.012, 3137727, 21699940.
8. Leung PS. Pancreatic RAS. Adv Exp Med Biol 2010, 690:89-105. 10.1007/978-90-481-9060-7_6, 20700839.
9. Wright JW, Harding JW. Brain renin-angiotensin-a new look at an old system. Prog Neurobiol 2011, 95:49-67. 10.1016/j.pneurobio.2011.07.001, 21777652.
10. Thatcher S, Yiannikouris F, Gupte M, Cassis L. The adipose renin-angiotensin system: role in cardiovascular disease. Mol Cell Endocrinol 2009, 302:111-117. 10.1016/j.mce.2009.01.019, 2748818, 19418627.
11. Marques-Lopes J, Pinto M, Pinho D, Morato M, Patinha D, Albino-Teixeira A, Tavares I. Microinjection of angiotensin II in the caudal ventrolateral medulla induces hyperalgesia. Neuroscience 2009, 158:1301-1310. 10.1016/j.neuroscience.2008.11.044, 19116162.
12. Prado WA, Pelegrini-da-Silva A, Martins AR. Microinjection of renin-angiotensin system peptides in discrete sites within the rat periaqueductal gray matter elicits antinociception. Brain Res 2003, 972:207-215. 10.1016/S0006-8993(03)02541-1, 12711094.
13. Pelegrini-da-Silva A, Martins AR, Prado WA. A new role for the renin-angiotensin system in the rat periaqueductal gray matter: angiotensin receptor-mediated modulation of nociception. Neuroscience 2005, 132:453-463. 10.1016/j.neuroscience.2004.12.046, 15802196.
14. Yien HW, Chan JY, Tsai HF, Lee TY, Chan SH. Participation of nucleus reticularis gigantocellularis in the antinociceptive effect of angiotensin III in the rat. Neurosci Lett 1993, 159:9-12. 10.1016/0304-3940(93)90785-J, 8264986.
15. Gu J, Liu X, Wang QX, Tan HW, Guo M, Jiang WF, Zhou L. Angiotensin II increases CTGF expression via MAPKs/TGF-beta1/TRAF6 pathway in atrial fibroblasts. Exp Cell Res 2012, 318:2105-2115. 10.1016/j.yexcr.2012.06.015, 22749815.
16. Yang L, Du C, Chen T, Li S, Nie W, Zhu W, Fan F, Zhu J, Yan H. Distinct MAPK pathways are involved in IL-23 production in dendritic cells cocultured with NK cells in the absence or presence of angiotensin II. Mol Immunol 2012, 51:51-56. 10.1016/j.molimm.2012.02.004, 22387269.
17. Chan SH, Hsu KS, Huang CC, Wang LL, Ou CC, Chan JY. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced pressor effect via activation of p38 mitogen-activated protein kinase in the rostral ventrolateral medulla. Circ Res 2005, 97:772-780. 10.1161/01.RES.0000185804.79157.C0, 16151022.
18. Ji RR, Baba H, Brenner GJ, Woolf CJ. Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity. Nat Neurosci 1999, 2:1114-1119. 10.1038/16040, 10570489.
19. Dai Y, Iwata K, Fukuoka T, Kondo E, Tokunaga A, Yamanaka H, Tachibana T, Liu Y, Noguchi K. Phosphorylation of extracellular signal-regulated kinase in primary afferent neurons by noxious stimuli and its involvement in peripheral sensitization. J Neurosci 2002, 22:7737-7745.
20. Ma W, Quirion R. Partial sciatic nerve ligation induces increase in the phosphorylation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) in astrocytes in the lumbar spinal dorsal horn and the gracile nucleus. Pain 2002, 99:175-184. 10.1016/S0304-3959(02)00097-0, 12237195.
21. Galan A, Cervero F, Laird JM. Extracellular signaling-regulated kinase-1 and -2 (ERK 1/2) mediate referred hyperalgesia in a murine model of visceral pain. Brain Res Mol Brain Res 2003, 116:126-134. 10.1016/S0169-328X(03)00284-5, 12941468.
22. Boyle DL, Jones TL, Hammaker D, Svensson CI, Rosengren S, Albani S, Sorkin L, Firestein GS. Regulation of peripheral inflammation by spinal p38 MAP kinase in rats. PLoS Med 2006, 3:e338. 10.1371/journal.pmed.0030338, 1560929, 16953659.
23. Tan-No K, Esashi A, Nakagawasai O, Niijima F, Tadano T, Sakurada C, Sakurada T, Bakalkin G, Terenius L, Kisara K. Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism. Brain Res 2002, 952:7-14. 10.1016/S0006-8993(02)03180-3, 12363399.
24. Tan-No K, Takahashi H, Nakagawasai O, Niijima F, Sato T, Satoh S, Sakurada S, Marinova Z, Yakovleva T, Bakalkin G, et al. Pronociceptive role of dynorphins in uninjured animals: N-ethylmaleimide-induced nociceptive behavior mediated through inhibition of dynorphin degradation. Pain 2005, 113:301-309. 10.1016/j.pain.2004.11.004, 15661437.
25. Tan-No K, Taira A, Wako K, Niijima F, Nakagawasai O, Tadano T, Sakurada C, Sakurada T, Kisara K. Intrathecally administered spermine produces the scratching, biting and licking behaviour in mice. Pain 2000, 86:55-61. 10.1016/S0304-3959(99)00312-7, 10779660.
26. Tan-No K, Esashi A, Nakagawasai O, Niijima F, Furuta S, Sato T, Satoh S, Yasuhara H, Tadano T. Intrathecally administered D-cycloserine produces nociceptive behavior through the activation of N-methyl-D-aspartate receptor ion-channel complex acting on the glycine recognition site. J Pharmacol Sci 2007, 104:39-45. 10.1254/jphs.FP0070203, 17452810.
27. Tan-No K, Takahashi K, Shimoda M, Sugawara M, Nakagawasai O, Niijima F, Sato T, Satoh S, Tadano T. S-(+)-fenfluramine-induced nociceptive behavior in mice: Involvement of interactions between spinal serotonin and substance P systems. Neuropeptides 2007, 41:33-38. 10.1016/j.npep.2006.10.003, 17140659.
28. Burkhalter J, Felix D, Imboden H. A new angiotensinergic system in the CNS of the rat. Regul Pept 2001, 99:93-101. 10.1016/S0167-0115(01)00238-5, 11384770.
29. Wu W, Zhang Y, Ballew JR, Fink G, Wang DH. Development of hypertension induced by subpressor infusion of angiotensin II: role of sensory nerves. Hypertension 2000, 36:549-552. 10.1161/01.HYP.36.4.549, 11040234.
30. Gebhart GF. Descending modulation of pain. Neurosci Biobehav Rev 2004, 27:729-737. 10.1016/j.neubiorev.2003.11.008, 15019423.
31. Georgieva D, Georgiev V. The role of angiotensin II and of its receptor subtypes in the acetic acid-induced abdominal constriction test. Pharmacol Biochem Behav 1999, 62:229-232. 10.1016/S0091-3057(98)00116-6, 9972688.
32. Raghavendra V, Chopra K, Kulkarni SK. Brain renin angiotensin system (RAS) in stress-induced analgesia and impaired retention. Peptides 1999, 20:335-342. 10.1016/S0196-9781(99)00040-6, 10447091.
33. Patil J, Schwab A, Nussberger J, Schaffner T, Saavedra JM, Imboden H. Intraneuronal angiotensinergic system in rat and human dorsal root ganglia. Regul Pept 2010, 162:90-98. 10.1016/j.regpep.2010.03.004, 2928989, 20346377.
34. Takai S, Song K, Tanaka T, Okunishi H, Miyazaki M. Antinociceptive effects of angiotensin-converting enzyme inhibitors and an angiotensin II receptor antagonist in mice. Life Sci 1996, 59:PL331-PL336. 10.1016/0024-3205(96)00527-9, 8937511.
35. Pavel J, Tang H, Brimijoin S, Moughamian A, Nishioku T, Benicky J, Saavedra JM. Expression and transport of Angiotensin II AT1 receptors in spinal cord, dorsal root ganglia and sciatic nerve of the rat. Brain Res 2008, 1246:111-122. 2680253, 18976642.
36. Pelegrini-da-Silva A, Rosa E, Guethe LM, Juliano MA, Prado WA, Martins AR. Angiotensin III modulates the nociceptive control mediated by the periaqueductal gray matter. Neuroscience 2009, 164:1263-1273. 10.1016/j.neuroscience.2009.09.004, 19747525.
37. Sung CS, Wen ZH, Chang WK, Chan KH, Ho ST, Tsai SK, Chang YC, Wong CS. Inhibition of p38 mitogen-activated protein kinase attenuates interleukin-1beta-induced thermal hyperalgesia and inducible nitric oxide synthase expression in the spinal cord. J Neurochem 2005, 94:742-752. 10.1111/j.1471-4159.2005.03226.x, 16033422.
38. Ji RR, Gereau RW, Malcangio M, Strichartz GR. MAP kinase and pain. Brain Res Rev 2009, 60:135-148. 10.1016/j.brainresrev.2008.12.011, 2666786, 19150373.
39. Enslen H, Raingeaud J, Davis RJ. Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6. J Biol Chem 1998, 273:1741-1748. 10.1074/jbc.273.3.1741, 9430721.
40. Gu YW, Su DS, Tian J, Wang XR. Attenuating phosphorylation of p38 MAPK in the activated microglia: a new mechanism for intrathecal lidocaine reversing tactile allodynia following chronic constriction injury in rats. Neurosci Lett 2008, 431:129-134. 10.1016/j.neulet.2007.11.065, 18191894.
41. Xu L, Huang Y, Yu X, Yue J, Yang N, Zuo P. The influence of p38 mitogen-activated protein kinase inhibitor on synthesis of inflammatory cytokine tumor necrosis factor alpha in spinal cord of rats with chronic constriction injury. Anesth Analg 2007, 105:1838-1844. 10.1213/01.ane.0000287660.29297.7b, 18042890.
42. Jin SX, Zhuang ZY, Woolf CJ, Ji RR. p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J Neurosci 2003, 23:4017-4022.
43. Terayama R, Omura S, Fujisawa N, Yamaai T, Ichikawa H, Sugimoto T. Activation of microglia and p38 mitogen-activated protein kinase in the dorsal column nucleus contributes to tactile allodynia following peripheral nerve injury. Neuroscience 2008, 153:1245-1255. 10.1016/j.neuroscience.2008.03.041, 18440713.
44. Tsuda M, Mizokoshi A, Shigemoto-Mogami Y, Koizumi S, Inoue K. Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia 2004, 45:89-95. 10.1002/glia.10308, 14648549.
45. Cui XY, Dai Y, Wang SL, Yamanaka H, Kobayashi K, Obata K, Chen J, Noguchi K. Differential activation of p38 and extracellular signal-regulated kinase in spinal cord in a model of bee venom-induced inflammation and hyperalgesia. Mol Pain 2008, 4:17. 10.1186/1744-8069-4-17, 2391153, 18445299.
46. Kim SY, Bae JC, Kim JY, Lee HL, Lee KM, Kim DS, Cho HJ. Activation of p38 MAP kinase in the rat dorsal root ganglia and spinal cord following peripheral inflammation and nerve injury. Neuroreport 2002, 13:2483-2486. 10.1097/00001756-200212200-00021, 12499853.
47. Svensson CI, Marsala M, Westerlund A, Calcutt NA, Campana WM, Freshwater JD, Catalano R, Feng Y, Protter AA, Scott B, Yaksh TL. Activation of p38 mitogen-activated protein kinase in spinal microglia is a critical link in inflammation-induced spinal pain processing. J Neurochem 2003, 86:1534-1544. 10.1046/j.1471-4159.2003.01969.x, 12950462.
48. Sweitzer SM, Peters MC, Ma JY, Kerr I, Mangadu R, Chakravarty S, Dugar S, Medicherla S, Protter AA, Yeomans DC. Peripheral and central p38 MAPK mediates capsaicin-induced hyperalgesia. Pain 2004, 111:278-285. 10.1016/j.pain.2004.07.007, 15363871.
49. Svensson CI, Hua XY, Protter AA, Powell HC, Yaksh TL. Spinal p38 MAP kinase is necessary for NMDA-induced spinal PGE(2) release and thermal hyperalgesia. Neuroreport 2003, 14:1153-1157. 10.1097/00001756-200306110-00010, 12821799.
50. Mizushima T, Obata K, Yamanaka H, Dai Y, Fukuoka T, Tokunaga A, Mashimo T, Noguchi K. Activation of p38 MAPK in primary afferent neurons by noxious stimulation and its involvement in the development of thermal hyperalgesia. Pain 2005, 113:51-60. 10.1016/j.pain.2004.09.038, 15621364.
51. Wang BW, Chang H, Kuan P, Shyu KG. Angiotensin II activates myostatin expression in cultured rat neonatal cardiomyocytes via p38 MAP kinase and myocyte enhance factor 2 pathway. J Endocrinol 2008, 197:85-93. 10.1677/JOE-07-0596, 18372235.
52. Hylden JL, Wilcox GL. Intrathecal morphine in mice: a new technique. Eur J Pharmacol 1980, 67:313-316. 10.1016/0014-2999(80)90515-4, 6893963.
53. Nakagawasai O, Hozumi S, Tan-No K, Niijima F, Arai Y, Yasuhara H, Tadano T. Immunohistochemical fluorescence intensity reduction of brain somatostatin in the impairment of learning and memory-related behaviour induced by olfactory bulbectomy. Behav Brain Res 2003, 142:63-67. 10.1016/S0166-4328(02)00383-2, 12798266.